Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Common Equity: 2020-2025

Historic Common Equity for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$1.1 billion.

  • Core Scientific's Common Equity fell 54.64% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 54.64%. This contributed to the annual value of -$820.2 million for FY2024, which is 37.40% down from last year.
  • Latest data reveals that Core Scientific reported Common Equity of -$1.1 billion as of Q3 2025, which was down 5.94% from -$1.1 billion recorded in Q2 2025.
  • Core Scientific's Common Equity's 5-year high stood at $1.3 billion during Q4 2021, with a 5-year trough of -$1.1 billion in Q3 2025.
  • In the last 3 years, Core Scientific's Common Equity had a median value of -$596.9 million in 2023 and averaged -$649.8 million.
  • As far as peak fluctuations go, Core Scientific's Common Equity spiked by 9,186,269.86% in 2021, and later slumped by 673.39% in 2023.
  • Core Scientific's Common Equity (Quarterly) stood at $1.3 billion in 2021, then plummeted by 130.52% to -$409.3 million in 2022, then plummeted by 45.83% to -$596.9 million in 2023, then crashed by 37.40% to -$820.2 million in 2024, then plummeted by 54.64% to -$1.1 billion in 2025.
  • Its Common Equity was -$1.1 billion in Q3 2025, compared to -$1.1 billion in Q2 2025 and -$181.5 million in Q1 2025.